All issues > Volume 48(9); 2005

Case Report

Korean J Pediatr. 2005;48(9):1004-1008. Published online September 15, 2005.

Successful Management with Vincristine after Failure of Prednisolone Therapy for Diffuse Neonatal Hemangiomatosis

Hak-Sung HS Lee¹, Soon-Young SY Heo¹, Won-Duck WD Kim¹

¹Department of Pediatrics, Daegu Fatima Hospital, Daegu, Korea

Correspondence Won-Duck WD Kim ,Email: neogubugi@yahoo.co.kr

Abstract

Hemangiomas are the most common benign tumors of infancy. Fifteen to 30% of these patients have multiple hemangiomas. Diffuse neonatal hemangiomatosis (DNH) is a disease that often has a fatal outcome if left untreated, and is characterized by multiple cutaneous and visceral hemangiomas. Corticosteroids are the commonly accepted first line treatment, but if no effect is seen, further treatment is required such as interferon, surgical excision, embolization and radiotherapy. Interferon is effective, but the neurologic sequela including spastic diplegia can be a complication. We experienced a case of DHN in a neonate. In this case, the baby presented with multiple cutaneous and visceral hemangiomas with Kasabach-Merritt syndrome (KMS) that included thrombocytopenia and consumptive coagulophthy. The baby was successfully treated with vincristine after the failure of steroid therapy.

Keywords :Diffuse neonatal hemangiomatosis , Vincristine